Please login to the form below

Not currently logged in
Email:
Password:

triglycerides

This page shows the latest triglycerides news and features for those working in and with pharma, biotech and healthcare.

BMS claims a win in mid-stage NASH trial

BMS claims a win in mid-stage NASH trial

For good measure the drug treatment also seemed to improved patients' blood lipid profiles, with triglycerides, low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol all shifting in the desired

Latest news

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    aureus and Shigellosis. Corporate acquisition. 190. Amarin/ Eddingpharm. VASCEPA (icosapent ethyl) - triglyceride level reduction.

  • Pharma deals during May 2014 Pharma deals during May 2014

    One year ago AstraZeneca acquired Omthera. On May 7 Epanova, a soft gelation capsule containing Omega-3, was approved by the FDA as an adjunct to diet to reduce triglyceride levels

  • Pharma deals during November 2012 Pharma deals during November 2012

    Pronova supplies the active ingredient in GSK's triglyceride lowering omega-3 drug Lovaza and, in addition, is developing competitor formulations – the most advanced being PRC-4016 for dyslipidaemia.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Channel purpose, change lives

    Ideas came to life through a multitude of means, from AstraZeneca’ s talking fish who discuss "love, life and triglycerides" to Cancer Council NSW’ s ‘ I Touch Myself Project’ that reinvented

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics